Efficacy of Varunadi Ghritha (polyherbal compound) in treated head and neck cancer cases as a biological response modifier
Authors
Divya Ravindran
Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, India
Indhu Hariharan
Integrated Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India
Richard Muwonge
Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France
Rejnish Kumar
Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, India
M Pillai
Integrated Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India
Kunnambath Ramadas
Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, India
Keywords:
Ayurveda, head and neck cancer, immunomodulation, loco-regional control, second primary tumour
Abstract
Persistent immune suppression is reported in Head and Neck Cancers (HNC) even after treatment and a higher recurrence rate was observed in patients with poor CD3 count. Loco regional recurrences and second primary tumours are the common forms of failure in head and neck cancers. Several agents have been tried to overcome this problem without much benefit. In Ayurveda, several plant based products have been reported to have anti-tumour and immunomodulatory properties.
Aim:
To test the role of Varunadi Ghritha, as an immunomodulator in apparently healthy, treated and controlled HNC patients and to evaluate its effectiveness in preventing locoregional relapses and development of second primary tumours.
Materials and Methods:
Total 78 patients of treated head and neck cancers were randomly selected for intervention and control group. Patients in the intervention group (n = 38) received Varunadi Ghritha, 5gms twice daily for one year and followed up to two years. Patients in the control group (n = 40) were followed up at regular intervals. Immune parameters were assessed in the peripheral blood at base line and at the end of administration of the study compound.
Results:
In the intervention group, mean percentage increase in CD3, CD19 and CD16 positive cells were significantly higher after the administration of the study compound compared to the control group indicating an immunomodulatory effect of the study compound. A non-significant improvement in disease control was observed in patients with advanced stage of disease in the intervention group.
Conclusion:
Administration of Varunadi Ghritha resulted in an increase in T cell counts in patients with treated HNC.
Keywords: Ayurveda, head and neck cancer, immunomodulation, loco-regional control, second primary tumour
Click on "Archives" to access the full archive of scientific preprints. You may use the categories and the search functionality to find select preprints you're interested in.
